Phase III trial of bolus 5-fluorouracil (5-FU)/folinic acid (FA) (MAYO) vs. weekly oxaliplatin (OXA) plus high dose 24h 5-FU infusion/FA in patients with advanced colorectal cancer (CRC)

Authors:
  • AGA. Grothey
    A. Grothey
  • TBT. Buechele
    T. Buechele
  • HKH. Kroening
    H. Kroening
  • KRK. Ridwelski
    K. Ridwelski
  • PRP. Reichardt
    P. Reichardt
  • AKA. Kretzschmar
    A. Kretzschmar
  • MCM. Clemens
    M. Clemens
  • HSH.J. Schmoll
    H.J. Schmoll

Abstract
No abstract available